文献速递糖尿病

美国糖尿病医疗支出1996至2013年变化及驱动因素

Health Care Spending on Diabetes in the U.S., 1996-2013.
PubMed 文献 · Diabetes Care · 2018-05-10

基于健康计量与评估研究所2013年疾病支出数据库,分析1996至2013年美国糖尿病医疗支出变化及驱动因素。

要点

  • 2013年糖尿病支出中处方零售药品占支出增长的57.6%,门诊医疗占23.5%。
  • 1996至2013年药品支出增长327.0%,次均支出增加使药品支出增长144.0%。
  • 次均支出是糖尿病医疗支出增长的最大驱动因素。

核心结论

  • 美国糖尿病医疗支出增加,次均支出是最大驱动因素。

研究设计与样本

  • 从健康计量与评估研究所2013年疾病支出数据库提取支出估计,覆盖1996至2013年每年38个年龄和性别组及6类医疗服务。
  • 疾病负担数据来自2016年全球疾病负担研究,通过衡量人口增长与老龄化、糖尿病患病率、服务利用及次均支出变化分析驱动因素。

主要发现

  • 2013年糖尿病医疗支出中,处方零售药品占支出增长的57.6%(53.8至62.1%),门诊医疗占23.5%(21.7至25.7%)。
  • 1996至2013年药品支出增长327.0%(222.9至456.6%)。
  • 次均支出增加使1996至2013年药品支出增长144.0%(87.3至197.3%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Health care spending on diabetes in the U.S. has increased dramatically over the past several decades. This research describes health care spending on diabetes to quantify how that spending has changed from 1996 to 2013 and to determine what drivers are increasing spending. RESEARCH DESIGN AND METHODS: Spending estimates were extracted from the Institute for Health Metrics and Evaluation's Disease Expenditure 2013 database. Estimates were produced for each year from 1996 to 2013 for each of 38 age and sex groups and six types of care. Data on disease burden were extracted from the Global Burden of Disease 2016 study. We analyzed the drivers of spending by measuring the impact of population growth and aging and changes in diabetes prevalence, service utilization, and spending per encounter. RESULTS: Spending on diabetes in the U.S. increased from $37 billion (95% uncertainty interval $32-$42 billion) in 1996 to $101 billion ($97-$107 billion) in 2013. The greatest amount of health care spending on diabetes in 2013 occurred in prescribed retail pharmaceuticals (57.6% [53.8-62.1%] of spending growth) followed by ambulatory care (23.5% [21.7-25.7%]). Between 1996 and 2013, pharmaceutical spending increased by 327.0% (222.9-456.6%). This increase can be attributed to changes in demography, increased disease prevalence, increased service utilization, and, especially, increases in spending per encounter, which increased pharmaceutical spending by 144.0% (87.3-197.3%) between 1996 and 2013. CONCLUSIONS: Health care spending on diabetes in the U.S. has increased, and spending per encounter has been the biggest driver. This information can help policy makers who are attempting to control future spending on diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Squires E, Duber H, Campbell M, et al. Health Care Spending on Diabetes in the U.S., 1996-2013. Diabetes Care. 2018. PMID: 29748431. doi:10.2337/dc17-1376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。